Validamycin B
CAS: 102583-47-1
Ref. 3D-CEA58347
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Product Information
- Antibiotic T 7545B
- 1,5-Dideoxy-4-O-β-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol
- D-chiro-Inositol, 1,5-dideoxy-4-O-β-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-
- D-chiro-Inositol, 1,5-dideoxy-4-O-β-D-glucopyranosyl-5-(hydroxymethyl)-1-[[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-, [1S-(1α,4α,5β,6α)]-
Validamycin B is a medicinal compound that has been found to have potential anticancer properties. This human analog acts as an inhibitor of certain proteins involved in the cell cycle, leading to apoptosis or programmed cell death in cancer cells. Validamycin B has been shown to be effective against various types of cancer, including lung, colon, and breast cancer. It inhibits the activity of kinases that are important for tumor growth and proliferation. The compound is excreted through urine and can be used as a diagnostic tool for detecting cancer. Validamycin B is a promising candidate for the development of novel anticancer drugs.
Chemical properties
Technical inquiry about: 3D-CEA58347 Validamycin B
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
